Kura Oncology, Inc. · NASDAQ:KURA
Montanova Capital, LLC reported a 9.70% stake in Kura Oncology, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Montanova Capital, LLC reported a 9.70% stake in Kura Oncology, Inc., 8,575,422 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 9.70%
- Shares
- 8,575,422
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Montanova Capital, LLC | 9.70% | 8,575,422 |
| Averill Master Fund, Ltd. | 8.80% | 7,805,540 |
| Aaron Cowen | 9.70% | 8,575,422 |
Source
Related
- Kura Oncology, Inc.
- Montanova Capital, LLC
- Kura Oncology, Inc. shareholders
- Schedule 13G/A · Montanova Capital, LLC · May 2, 2025
- Schedule 13G/A · Montanova Capital, LLC · Feb 13, 2025
- Form 4 · Ford Kathleen · Sep 29, 2026
- Form 4 · Leoni Mollie · Sep 29, 2026
- Form 4 · Powl Brian T. · Sep 29, 2026
- Form 4 · Bair Teresa Brophy · Sep 29, 2026
- Form 4 · Doyle Thomas James · Sep 29, 2026